Skip to main content
Journal cover image

Ribonucleotide reductase (RRM1) expression in non-small cell lung cancer (NSCLC): implications for personalizing gemcitabine-based therapy

Publication ,  Conference
Gandara, DR; Mack, PC; Omori, A; Grimminger, P; Joshi, M-BM; Harpole, DH; Danenberg, KD
Published in: JOURNAL OF THORACIC ONCOLOGY
September 1, 2009

Duke Scholars

Published In

JOURNAL OF THORACIC ONCOLOGY

ISSN

1556-0864

Publication Date

September 1, 2009

Volume

4

Issue

9

Start / End Page

S401 / S402

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Gandara, D. R., Mack, P. C., Omori, A., Grimminger, P., Joshi, M.-B., Harpole, D. H., & Danenberg, K. D. (2009). Ribonucleotide reductase (RRM1) expression in non-small cell lung cancer (NSCLC): implications for personalizing gemcitabine-based therapy. In JOURNAL OF THORACIC ONCOLOGY (Vol. 4, pp. S401–S402). LIPPINCOTT WILLIAMS & WILKINS.
Gandara, David R., Philip C. Mack, Akiko Omori, Peter Grimminger, Mary-Beth M. Joshi, David H. Harpole, and Kathleen D. Danenberg. “Ribonucleotide reductase (RRM1) expression in non-small cell lung cancer (NSCLC): implications for personalizing gemcitabine-based therapy.” In JOURNAL OF THORACIC ONCOLOGY, 4:S401–2. LIPPINCOTT WILLIAMS & WILKINS, 2009.
Gandara DR, Mack PC, Omori A, Grimminger P, Joshi M-BM, Harpole DH, et al. Ribonucleotide reductase (RRM1) expression in non-small cell lung cancer (NSCLC): implications for personalizing gemcitabine-based therapy. In: JOURNAL OF THORACIC ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS; 2009. p. S401–2.
Gandara, David R., et al. “Ribonucleotide reductase (RRM1) expression in non-small cell lung cancer (NSCLC): implications for personalizing gemcitabine-based therapy.” JOURNAL OF THORACIC ONCOLOGY, vol. 4, no. 9, LIPPINCOTT WILLIAMS & WILKINS, 2009, pp. S401–02.
Gandara DR, Mack PC, Omori A, Grimminger P, Joshi M-BM, Harpole DH, Danenberg KD. Ribonucleotide reductase (RRM1) expression in non-small cell lung cancer (NSCLC): implications for personalizing gemcitabine-based therapy. JOURNAL OF THORACIC ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS; 2009. p. S401–S402.
Journal cover image

Published In

JOURNAL OF THORACIC ONCOLOGY

ISSN

1556-0864

Publication Date

September 1, 2009

Volume

4

Issue

9

Start / End Page

S401 / S402

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology